Evidence map›Paper›PMID 42232030›Full record

ArticleChem & bio engineering2026

Modular Biosurface Engineering of Magnetotactic Bacteria for Multimodal Synergistic Cancer Therapy.

Qilong Li, Wangqing Li, Xuefei Sun, Feng Feng, Zhengdong Cheng, Wenchao Li, Li Yao, Xiuyu Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chem & bio engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qilong LiBeijing National Laboratory for Molecular Sciences, State Key Laboratory for Structural Chemistry of Unstable and Stable Species, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
Wangqing LiInstitute of Advanced Equipment, College of Energy Engineering, Zhejiang University, Hangzhou 310027, China.
Xuefei SunBeijing National Laboratory for Molecular Sciences, State Key Laboratory for Structural Chemistry of Unstable and Stable Species, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
Feng FengInstitute of Advanced Equipment, College of Energy Engineering, Zhejiang University, Hangzhou 310027, China.
Zhengdong ChengCollege of Chemical and Biological Engineering, Zheiiang University, Hangzhou 310058, China.ORCID https://orcid.org/0000-0001-7720-1909
Wenchao LiThe Seventh Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100010, China.
Li YaoBeijing National Laboratory for Molecular Sciences, State Key Laboratory for Structural Chemistry of Unstable and Stable Species, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China.ORCID https://orcid.org/0000-0002-7226-7551
Xiuyu WangInstitute of Advanced Equipment, College of Energy Engineering, Zhejiang University, Hangzhou 310027, China.ORCID https://orcid.org/0000-0001-6293-988X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial-mediated cancer therapy shows therapeutic potential yet remains constrained by bioavailability and biosafety challenges. We introduce a scalable, modular biosurface-engineering platform for functionalizing wild-type magnetotactic bacteria (

Indexed as

Antitumor ImmunityBiosurface EngineeringCancer TherapyMagnetotactic BacteriaTumor Targeting

Identifiers

PMID42232030
PMCPMC13223873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.